Gemfibrozil prevents major coronary events by increasing HDL-cholesterol and more

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.7, 2001-07, pp. : 1187-1189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Treating Low HDL-Cholesterol in the Primary Prevention of Coronary Heart Disease

By Hay Joel W.

PharmacoEconomics, Vol. 23, Iss. 2, 2005-01 ,pp. : 133-141

Adis International

Access to resources Recommend Favorite

A series of hydrazone derivatives that elevate HDL-cholesterol

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 9, 1999-09 ,pp. : 1293-1298

Informa Healthcare

Access to resources Recommend Favorite

Oxymetholone: First report of a decrease in HDL-cholesterol levels: case report

Reactions Weekly, Vol. 1, Iss. 1177, 2007-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Paradoxically, serum HDL-cholesterol levels are lowered by concomitant treatment with fenofibrate and rosiglitazone

Reactions Weekly, Vol. 1, Iss. 1019, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Paradoxically, serum HDL-cholesterol levels are lowered by concomitant treatment with fenofibrate plus rosiglitazone

Inpharma, Vol. 1, Iss. 1455, 2004-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite